Showing results (971-980 of 5,667) with videos related to
Sort By:
Pageof 567
Drug Design, Development and Therapy|November 23, 2018
Hydralazine HCl rapidly disintegrating sublingual tablets: simple dosage form of higher bioavailability and enhanced clinical efficacy for potential rapid control on hypertensive preeclampsiaSamar Genedy, Ahmed Khames, Amal Hussein, et al.Drug Design, Development and Therapy|November 23, 2018
Erratum: The effect of food and liquid pH on the integrity of enteric-coated beads from cysteamine bitartrate delayed-release capsules [Corrigendum]Drug Design, Development and Therapy|January 27, 2017
Spotlight on opicapone as an adjunct to levodopa in Parkinson's disease: design, development and potential place in therapyÁdám Annus, László VécseiDrug Design, Development and Therapy|November 16, 2016
Evaluating the cytotoxic effects of the water extracts of four anticancer herbs against human malignant melanoma cellsBinbing Ling, Deborah Michel, Meena Kishore Sakharkar, et al.Drug Design, Development and Therapy|November 16, 2016
Erratum: Mechanism and pharmacological rescue of berberine-induced hERG channel deficiency [Corrigendum]Drug Design, Development and Therapy|November 16, 2016
Fenretinide inhibits macrophage inflammatory mediators and controls hypertension in spontaneously hypertensive rats via the peroxisome proliferator-activated receptor gamma pathwayChing-Han Lin, Shang-Yu Lee, Chun-Cheng Zhang, et al.Drug Design, Development and Therapy|April 15, 2017
Mirtazapine for symptom control in refractory gastroparesisMark Malamood, Aaron Roberts, Rahul Kataria, et al.Drug Design, Development and Therapy|April 15, 2017
Spotlight on romiplostim in the treatment of children with chronic immune thrombocytopenia: design, development, and potential place in therapyDavid Buchbinder, Diane Nugent, Loan HsiehDrug Design, Development and Therapy|April 21, 2017
Rifapentine-linezolid-loaded PLGA microspheres for interventional therapy of cavitary pulmonary tuberculosis: preparation and in vitro characterizationJieyun Huang, Zhi Chen, Ying Li, et al.Drug Design, Development and Therapy|April 21, 2017
β3-Adrenoceptor activation upregulates apolipoprotein A-I expression in HepG2 cells, which might further promote cholesterol efflux from macrophage foam cellsXia-Qing Gao, Yan-Fang Li, Zhi-Li JiangPageof 567